Dual-drug nanotherapy crosses blood–brain barrier, improving survival in preclinical glioblastoma models

Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, according to a study published in Communications Medicine. The strategy extended survival in preclinical models of glioblastoma, the most aggressive form of brain cancer.

Originally published at Phys.org